The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical and pathologic characteristics of patients with PI3K-mutant breast cancers.
M. Cooper Lloyd
No relevant relationships to disclose
Melinda Sanders
No relevant relationships to disclose
Maria Gabriela Kuba
No relevant relationships to disclose
Jaime Farley
No relevant relationships to disclose
Darson Lai
No relevant relationships to disclose
Zengliu Su
No relevant relationships to disclose
Ingrid A. Mayer
No relevant relationships to disclose
Julie Ann Means-Powell
No relevant relationships to disclose
Cindy Vnenzak-Jones
No relevant relationships to disclose
Mia Alyce Levy
No relevant relationships to disclose
William Pao
No relevant relationships to disclose
Carlos L. Arteaga
No relevant relationships to disclose
Vandana Gupta Abramson
No relevant relationships to disclose